The glymphatic system: implications for drugs for central nervous system diseases

TJ Lohela, TO Lilius, M Nedergaard - Nature Reviews Drug Discovery, 2022 - nature.com
In the past decade, evidence for a fluid clearance pathway in the central nervous system
known as the glymphatic system has grown. According to the glymphatic system concept …

Dexmedetomidine in enhanced recovery after surgery (ERAS) protocols for postoperative pain

AD Kaye, DJ Chernobylsky, P Thakur… - Current pain and …, 2020 - Springer
Abstract Purpose of Review Effective acute pain management has evolved considerably in
recent years and is a primary area of focus in attempts to defend against the opioid …

The role of microRNA-185 in the pathogenesis of human diseases: a focus on cancer

S Pordel, M Khorrami, F Saadatpour, D Rezaee… - … -Research and Practice, 2023 - Elsevier
MicroRNAs (miRNAs) are a widely-studied class of non-coding RNAs characterized by their
short length (18-25 nucleotides). The precise functions of miRNAs are not well-elucidated; …

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons

HM Al-Kuraishy, AI Al-Gareeb, L Alkazmi… - …, 2022 - Springer
High-mobility group box 1 (HMGB1), a multifunctional nuclear protein, exists mainly within
the nucleus of all mammal eukaryotic cells. It is actively secreted by the necrotic cells as a …

Understanding the neural mechanisms of general anesthesia from interaction with sleep–wake state: a decade of discovery

WW Bao, S Jiang, WM Qu, WX Li, CH Miao… - Pharmacological …, 2023 - ASPET
The development of cutting-edge techniques to study specific brain regions and neural
circuits that regulate sleep–wake brain states and general anesthesia (GA), has increased …

Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial

Y Shehabi, A Serpa Neto, BD Howe, R Bellomo… - Intensive care …, 2021 - Springer
Purpose To quantify potential heterogeneity of treatment effect (HTE), of early sedation with
dexmedetomidine (DEX) compared with usual care, and identify patients who have a high …

Mechanisms of dexmedetomidine in neuropathic pain

Y Zhao, J He, N Yu, C Jia, S Wang - Frontiers in neuroscience, 2020 - frontiersin.org
Dexmedetomidin is a new-generation, highly selective α2 adrenergic receptor agonist with a
large number of advantages, including its sedative and analgesic properties, its ability to …

Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats

JF Perez-Zoghbi, W Zhu, MR Grafe… - BJA: British Journal of …, 2017 - academic.oup.com
Background. Exposure of infant animals to clinically used anaesthetics is associated with
acute structural brain abnormalities and development functional alterations. The α2 …

[HTML][HTML] Opioid-free anesthesia: A systematic review and meta-analysis

ML Feenstra, S Jansen, WJ Eshuis… - Journal of clinical …, 2023 - Elsevier
Study objective To evaluate all available evidence thus far on opioid based versus opioid-
free anesthesia and its effect on acute and chronic postoperative pain. Design Systematic …

Could dexmedetomidine be repurposed as a glymphatic enhancer?

NDÅ Persson, P Uusalo, M Nedergaard… - Trends in …, 2022 - cell.com
Cerebrospinal fluid (CSF) flows through the central nervous system (CNS) via the
glymphatic pathway to clear the interstitium of metabolic waste. In preclinical studies …